Avanir Pharmaceuticals, Inc. (AVNR) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bearish

50% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/14/2014 1 month $11.85 $12.86 +8.51% -8 Active
Comments:
outofbounds1 outofbounds1 08/26/2014 3 months $6.13 $12.86 +109.76% 109 Active
Comments:
felperna felperna 02/06/2014 1 month $3.44 $5.00 +45.35% 45 Ended
Comments: my tschnical analysis
TinVestor1 TinVestor1 09/20/2013 1 week $4.33 $3.15 -27.25% -27 Ended
Comments: Upcoming product launch will be successful
Farrukh Farrukh 08/22/2013 1 week $5.06 $3.15 -37.75% 37 Ended
Comments: Technicals suggest its overbought and needs correction
marcelo aniloel zampolli marcelo aniloel zampolli 07/18/2013 3 months $4.63 $4.48 -3.14% 3 Ended
Comments:
Faz Trader Faz Trader 07/18/2013 3 months $4.63 $3.15 -31.89% -31 Ended
Comments: huge potential buyout target $12
InvestorsXpress InvestorsXpress 04/26/2013 1 day $3.20 $3.27 +2.19% 2 Ended
Comments:
tambor tambor 04/06/2013 3 months $2.65 $4.28 +61.51% 61 Ended
Comments:
rich888 rich888 01/10/2012 3 months $2.20 $3.21 +45.68% 45 Ended
Comments: Industry sector growing or poised for growth
jpdipietro jpdipietro 11/04/2010 3 months $4.50 $3.21 -28.78% -28 Ended
Comments: Upcoming product launch will be successful
GUSJEAN GUSJEAN 07/27/2010 3 months N/A Ended
Comments: ,GREAT POTENTIAL DRUGS
arcontes arcontes 03/16/2010 3 months N/A Ended
Comments: arcontes
Buffetson Buffetson 01/05/2010 3 months N/A Ended
Comments: Strong Buy !

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.